Cancer Research UK logo.
SearchDonate
  • Search

A study to learn more about the types and outcomes of low risk myelodysplastic syndromes (MDS)

Overview

Cancer types:

Blood cancers, Myelodysplastic syndrome (MDS)

Status:

Open

Phase:

Other

Details

This study is building a record of information about a group of disorders called myelodysplastic syndromes (MDS). The bone marrow is the body’s blood cell factory. In myelodysplastic syndromes (MDS) the bone marrow does not produce enough blood cells. This can lead to problems such as , bleeding or infections. Sometimes, MDS can develop into leukaemia. But the risk of this happening is different for each person.

Recruitment start: 1 April 2008

Recruitment end: 31 December 2025

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Dr Catherine Cargo

Supported by

European LeukaemiaNet MDS Work Group

Experimental Cancer Medicine Centre (ECMC)

Novartis

University Medical Center Nijmegen St Radboud

Last reviewed: 12 May 2025

CRUK internal database number: 4169

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.